Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: 313644-32-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
The test item DINCD was assessed for skin sensitizing in a modified Local Lymph Node Assay.
Based on the results, DINCD is not regarded as a skin sensitizer.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 01.10.2014 to 18.12.2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: HsdWin:NMRI
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Nederland, Kreuzelweg 53, 5960 AD Horst, The Netherlands
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 10 weeks
- Weight at study initiation: 29- 36g
- Housing: During the adaptation period up to 8 mice were housed together in conventional
Makrolon® type III cages, cages were changed at least twice a week. While during the study
period the animals were single-housed in type II cages.
All the animals used in this study were kept in the same room. In case animals from other
toxicological studies were kept in the same room, adequate spatial separation and appropriate
organization of the working procedures ensured that animals could not be confused.
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 6 days
- Indication of any skin lesions: no, only healthy animals showing no signs of disease were used in the study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2 °C
- Humidity (%): 40-70%
- Air changes (per hr): About 1 0 changes per hour
- Photoperiod (hrs dark / hrs light): 12 h/12 h, with artificial illumination
- IN-LIFE DATES: From: 13.10.2014 To: 16.10.14 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Test item: 0 % (vehicle control), 25 %, 50 %and 100 %.
The test item was formulated immediately before each administration in acetone/Olive oil 4:1 (A/00)
Group 1 - Vehicle (A/OO)
Group 2 - 25% DINCD (in A/OO)
Group 3 - 50% DINCD (in A/OO)
Group 4 - 100% DINCD - No. of animals per dose:
- 6 female per group (4 groups)
- Details on study design:
- MAIN STUDY
The methods used in this study are in principle specified in guidelines (OECD 406, 1992;
EPA guideline OPPTS 870.2600, Skin Sensitization, March 2003; updated
OECD TG 429, 2010). A further modification was done by including the measurement of the ear swelling after treatment leading to a much more simplified and reliable assay (Integrated Model for the Differentiation of Skin reactions
(IMDS, (1 )). By comparing the specific immune reaction induced by the test item in the
draining lymph nodes (LN cell counts I LN weights) with the immediate non-specific acute
skin reaction (ear swelling I ear weight) it is possible to discriminate the irritant potential from the sensitizing potential of the compound tested. International standards have been
successfully classified using this modification (2). Such modifications are also authorized in
the updated OECD guideline 429 (20 1 0).
TREATMENT PREPARATION AND ADMINISTRATION:
The test item in the formulation, the test item pure or the vehicle were applied epicutaneously onto the dorsal part of both ears of the animals. This treatment was repeated on three consecutive days ( d 1, d2 and d3).
The volume administered was 25 µl/ear.
Based on our experiences with this test system and the known properties of the test item the
following concentrations were used: 0 % (vehicle control), 25 %, 50 % and 100 %. - Statistics:
- When it was statistically reasonable, the values from treated groups were compared with those
from the control group(s; vehicle) by a one-way analysis of variance (ANOVA) when the
variances are considered homogeneous according to a homogeneity testing like Cochran's
test. Alternatively, if the variances are considered to be heterogenous (p:::; 0.05), a
non-parametric Kruskal-Wallis test has been used (Kruskal-Wallis ANOV A) at significance
levels of 5 %. Two sided multiple test procedures were done according to Dunnett or
Bonferroni-Holrn, respectively. Outlying values in the LN weights were eliminated at a
probability level of99% by Nalimov's method. In addition, for the LLNA/IMDS the smallest
significant differences in the means were calculated by Scheffe's method, which can be used
for both equal and unequal sample sizes. - Key result
- Parameter:
- SI
- Value:
- 1
- Variability:
- +/- 16.22 (SD in %)
- Test group / Remarks:
- Vehicle
- Key result
- Parameter:
- SI
- Value:
- 1.12
- Variability:
- +/- 23.98 (SD in %)
- Test group / Remarks:
- 25 %
- Key result
- Parameter:
- SI
- Value:
- 1.12
- Variability:
- +/- 30.36 (SD in %)
- Test group / Remarks:
- 50 %
- Key result
- Parameter:
- SI
- Value:
- 1.22
- Variability:
- +/- 31.01 (SD in %)
- Test group / Remarks:
- 100 %
- Conclusions:
- In conclusion, these results show that the test item DINCD has no sensitizing potential in
mice after dermal application up to and including a concentration of 100 %. The increases in
ear swelling, however, point to a weak to moderate irritant potential of the test item DINCD.
Therefore, the concentration of 100 % turned out to be the NOEL for the parameters
investigated in this study with respect to skin sensitization.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The test item DINCD was assessed for skin sensitizing in a modified Local Lymph Node Assay. Compared to vehicle (A/00) treated animals there were no increases regarding the cell counts and the weights of the draining lymph nodes in any dose group. The "positive level" of the stimulation index for the cell counts, which is 1.4
( 1, 2) has never been reached or exceeded.
In conclusion, these results show that the test item DINCD has no sensitizing potential in
mice after dermal application up to and including a concentration of 100 %.
Therefore, the concentration of 100 % turned out to be the NOEL for the parameters
investigated in this study with respect to skin sensitization.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the available study, the test substance is not classified for sensitisation according to EC Regulation No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
